THE WIREANONYMISED PREVIEW
A UK global-health foundation and a German life-sciences company put $50M behind AMR transmission research
A new global health program opens its abstract portal, widening non-dilutive funding for teams working at the antibiotic resistance and one-health interface.
SourcesLinks for Pro users
PRO
Read the full briefing
The named actors, the analyst’s take, and the related opportunities are all in the Pro briefing. Free accounts see the anonymised preview above.